Pacer Advisors, Inc. Coherus Bio Sciences, Inc. Transaction History

Pacer Advisors, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$12.95 - $15.41 $1.37 Million - $1.62 Million	-105,431 Closed	0 $0
Q1 2021 Apr 05, 2021	BUY	$14.42 - $21.39 $1.14 Million - $1.69 Million	78,830 Added 296.34%	105,431 $1.54 Million
Q4 2020 Jan 20, 2021	BUY	$16.56 - $18.94 $90,616 - $103,639	5,472 Added 25.9%	26,601 $462,000
Q3 2020 Oct 19, 2020	BUY	$17.41 - $19.89 $197,411 - $225,532	11,339 Added 115.82%	21,129 $388,000
Q2 2020 Jul 29, 2020	BUY	$14.43 - $19.16 $141,269 - $187,576	9,790 New	9,790 $175,000
Q4 2018 Feb 13, 2019	SELL	$8.65 - $16.28 $41,234 - $77,606	-4,767 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$14.45 - $20.25 $68,883 - $96,531	4,767 New	4,767 $79,000
Q1 2018 May 14, 2018	SELL	$9.1 - $13.7 $15,697 - $23,632	-1,725 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$8.35 - $14.4 $14,403 - $24,840	1,725	1,725 $15,000

132

76.9M

40.7K

50.1K

Ticker CHRS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 77,724,600
Market Cap $91.7M
Description
Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilar and immuno-oncology market primarily in the United States. The company markets UDENYCA, a biosimilar to Neulasta, a long-acting granulocyte stimulating colony factor in the United States. Its pipeline products include biosimilars of Humira, Avastin, and Lucentis. T...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.